Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis

SIMPLE SUMMARY: Following neoadjuvant systemic therapy (NAST), patients who were clinically node-negative at diagnosis still routinely undergo sentinel lymph node biopsy (SLNB) to detect nodal disease. Surgical staging of the axilla is currently the standard of care, including for those who achieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamoodi, Munaser, Wazir, Umar, Mokbel, Kinan, Patani, Neill, Varghese, Jajini, Mokbel, Kefah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340379/
https://www.ncbi.nlm.nih.gov/pubmed/37444434
http://dx.doi.org/10.3390/cancers15133325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340379/
https://www.ncbi.nlm.nih.gov/pubmed/37444434
http://dx.doi.org/10.3390/cancers15133325

Ejemplares similares